{
    "N/R/U": null,
    "Applicant": "GlaxoSmithKline Biologicals",
    "BLA Number": "125614",
    "Proprietary Name": "Shingrix",
    "Proper Name": "Zoster Vaccine Recombinant, Adjuvanted",
    "BLA Type": "351(a)",
    "Strength": "50UG",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "July 23, 2021",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": " ",
    "Supplement Number": "398",
    "Submission Type": "Supplement",
    "License Number": "1617",
    "Product Number": "002",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}